Patients with FLT3-ITD AML had significantly higher median white blood cell counts (44.5 x 109/L, IQR 12.0-110.1) compared to those with wild-type FLT3 AML (23.5 x 109/L, IQR 7.1-62.1) (p=0.002). This evidence concerns the gene FLT3 and acute myeloid leukemia.